Heredity and Phenotype Intervention (HAPI) Heart Study
NCT00664040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 868
Last updated 2022-07-26
Summary
Cardiovascular disease (CVD) is the leading cause of death in the United States and many people that die of heart disease have no previous symptoms. This study will look specifically at the response to four short-term environmental exposures including: the body's response to a cold stimulus, to a high fat milk shake, to aspirin, and to a high and low salt diet. These interventions are all known to influence CVD and people can have different responses to these interventions, which may be due, at least in part, to differences in genetic make up.
Conditions
Interventions
- OTHER
-
Aspirin
The aspirin intervention (81 mg per day) will last a total of 14 days. Pills will be provided in a pre-loaded pillbox. The field team will visit the subject at his/her home at least once to insure adherence to the aspirin intervention and to monitor for adverse side effects. On day 14 of the aspirin intervention, the subject will visit the clinic for a fasting blood draw for platelet aggregation and inflammatory marker studies. A pill count will be performed to assess adherence. The subject can miss up to four aspirin doses over the two-week period; however, an aspirin must be taken each day for the three days prior to clinic visit 2. The aspirin intervention can be extended for up to three days (17 days total) to meet the latter criteria. If more than four doses were missed, then the physician should be contacted and the patient should be withdrawn from the aspirin intervention. Platelet aggregation will be measured 1 hour after the last dose of aspirin.
- OTHER
-
Cold Pressor Test
This intervention consists of the participant placing his or her hand and wrist into ice water for 2½ minutes. The blood pressure is taken before and after the arm is removed from the water. An ultrasound machine is used to take pictures of the brachial artery in the left arm before and after the arm is removed from the water.
- OTHER
-
High Fat Meal
The participants are given a high fat milk shake consisting of 83% fat. Blood samples are drawn from a catheter placed in the participant's arm prior to the test. The samples are drawn before the milk shake and at 1, 2, 3, 4, and 6 hours after the milk shake is consumed. Before and at 2, 4 and 6 hours following the meal the ultrasound is used to obtain images of the brachial artery.
- OTHER
-
Dietary Salt
The salt intervention will consist of 6 days of an isocaloric high salt diet (270 mmol/d) followed by a washout period of at least 8 days and then a low salt diet (40 mmol/d). All food will be prepared by a registered dietician and dietary technicians in a specially equipped kitchen. The specific foods will consist of approximately 50% carbohydrates, 35% fat, and 15% protein. Dietary potassium will remain constant at 120 mmol/d. A food diary will be kept for each diet and subjects will be instructed to eat only the food provided. A field nurse will visit the home on days 3 and 5 of each diet to insure that neither diet is acutely affecting the health status of the subject. A first AM void spot urine will be obtained to measure sodium, potassium and creatinine on the 4th, 5th, and 6th days of each diet to insure compliance. Blood pressure will be measured using an ambulatory blood pressure monitor for 24 hours on the last day of each diet.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of Maryland, Baltimore
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-05-31
- Completion
- 2006-08-31
More Related Trials
-
Inflammation Markers Over Time in Cardiovascular Disease
NCT00005692 ·Status: COMPLETED
-
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease
NCT00001881 ·Status: COMPLETED
-
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
NCT03440697 ·Status: ACTIVE_NOT_RECRUITING
-
Epidemiology of Decline in Heart Disease Mortality
NCT00005162 ·Status: COMPLETED
-
Genetic Epidemiology of Change in CVD Risk Factors
NCT00037440 ·Status: COMPLETED
-
Antecedents of Hypertension: Role of Race and Stress
NCT00005238 ·Status: COMPLETED
-
Family Heart Study (FHS)
NCT00005136 ·Status: COMPLETED
-
Epidemiology of Acute Phase Protein and CHD
NCT00005371 ·Status: COMPLETED
-
Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease
NCT00101517 ·Status: COMPLETED
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
NCT05216042 ·Status: RECRUITING ·Phase: NA
-
Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart
NCT02885740 ·Status: UNKNOWN ·Phase: NA
-
The Perceived Impact of Children s Risk Status for Hypertrophic Cardiomyopathy on Families: an Exploratory Study
NCT01160536 ·Status: COMPLETED
-
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
NCT06280820 ·Status: ENROLLING_BY_INVITATION
-
Screening for Inherited Heart Disease
NCT00001746 ·Status: COMPLETED
-
Improving Cardiovascular Treatment Approaches Among Minorities
NCT00101478 ·Status: COMPLETED
-
Genetic Determinants of Sudden Cardiac Death
NCT00064558 ·Status: COMPLETED
-
Genetic Markers of CHD Risk in Men and Women
NCT00090454 ·Status: COMPLETED
-
Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers
NCT03038750 ·Status: TERMINATED
-
Diet, Genetics, and CVD Risk Factor Response in Blacks
NCT00079703 ·Status: COMPLETED
-
Genetic Predictors of Incident Cardiovascular Disease
NCT00035672 ·Status: WITHDRAWN
-
Common Variants in Candidate Genes and Premature MI Risk
NCT00005488 ·Status: COMPLETED
-
The Genetics of Cardiomyopathy and Heart Failure
NCT00703443 ·Status: WITHDRAWN
-
Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups
NCT00377702 ·Status: COMPLETED
-
Genetic Architecture of Plasma T-PA and PAI-1
NCT00007410 ·Status: COMPLETED
-
PREdisposition Genetical in Cardiac Insufficiency = Genetic Predisposition to Heart Failure
NCT01113268 ·Status: TERMINATED ·Phase: NA